MetaHint
MTHT - # 621 ActiveKorean Asset
-
Rating Score 45.69Rating Grade C
- Rating Version APYWA-v1.1 / Rating Date 2026-04-13
Overview
MetaHint (MTHT) is a utility token that supports a blockchain-based personalized healthcare and AI analytics platform. Through AI-driven health recommendations, decentralized identity (DID), and verifiable health data ownership and reward mechanisms, the platform enables users to securely utilize their health data and receive incentives.
Metric Radar Chart
Metric Bar Chart
Metric Trends
| Total Rating Score | TH3Uptrend |
|---|---|
| Market Accessibility | TNNeutral |
| Development Activity | TH1Strong Uptrend |
| Market Liquidity | TNNeutral |
| Community Engagement | TH1Strong Uptrend |
| Risk & Security | TNNeutral |
Total Rating Score Trend
Market Data
- Token Price $0.675462 (↗0.38%)
- Volume (24h) $10.68K (↗152,514.29%)
- Market Cap $115.67M (↗3.11%)
-
Circulating Supply
171,250,003 MTHT
0 MTHT
(Source : Coinmarketcap , Coingecko )
Listed Exchanges
- Korean
-
- Global
-
×
View All Exchanges
- Korean
-
- Global
-
Community Info
X (Twitter) Tweets (Last 30 Days)
221 (+107)
Development Info
-
GitHub Account
jojo-1245
-
Stars
15 (-)
- Commits (Last 3 Months) 1.17K (-)
Security Audit Info
- Security Audit Status CertiK
- CertiK Code Security Score 82 pts
(Source : Coinmarketcap , CertiK Skynet )
Issue Info
- Trading History
- 2025.12.23 [고팍스] 거래소에 신규 거래 지원됩니다
- Risk History
- No records found
View Full History
| Category | Date | Exchange | Link | Grade | Details |
|---|---|---|---|---|---|
| Regular Evaluation | 2026-04-13 | - | - | C(45.69) | [AW-0137-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2026-04-06 | - | - | C(45.27) | [AW-0136-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2026-03-30 | - | - | C-(44.82) | [AW-0135-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2026-03-23 | - | - | C-(40.83) | [AW-0134-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2026-03-16 | - | - | D(39.03) | [AW-0133-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2026-03-09 | - | - | D(37.71) | [AW-0132-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2026-03-02 | - | - | D(38.85) | [AW-0131-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2026-02-23 | - | - | D(38.63) | [AW-0130-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2026-02-16 | - | - | D(39.08) | [AW-0129-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2026-02-09 | - | - | D(39.36) | [AW-0128-정기] 평가가 완료되었습니다. |
- Disclaimer
-
The ratings provided by APYWA (hereinafter 'the Company') are conducted via an automated system based on public data and are pure data-driven analysis results with no subjective elements. This rating material includes evaluations on five key metrics: Market Accessibility, Development Activity, Market Liquidity, Community Engagement, and Security. All information provided is for reference purposes only.
Our ratings are not intended as investment advice or recommendations, and we do not guarantee the accuracy, completeness, or timeliness of the information. Users must make their own investment decisions based on the provided data, and the Company bears no legal liability for any resulting losses or damages.
While the rating material is processed automatically based on reliable data, discrepancies with actual market conditions may occur due to data limitations. Therefore, the Company is not liable for any damages arising from the use of the provided information. All information contained herein is the property of the Company and may not be reproduced, distributed, or modified without prior approval.